Skip to main content

Qiagen Microbial Insights AR

Qiagen has launched Microbial Insights AR (QMI-AR), an integrated genomic database that provides curated, single-point entry access to four of the world's largest knowledgebases on antimicrobial resistance. Specifically, it integrates the Comprehensive Antibiotic Resistance Database (CARD), ResFinder, a National Institutes of Health AMRFinder database of resistance genes, as well as the ARG-ANNOT database of peptide markers. According to Qiagen, the database complements ARESdb, a comprehensive, regularly updated genomic knowledgebase on clinically relevant antibiotic resistance strains that the firm has made available to the global research community through a partnership with Ares-Genetics, a Curetis subsidiary. Qiagen said that it will offer QMI-AR through the CLC Microbial Genomics Module, an extension to the CLC Genomics Workbench bioinformatics software.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.